Keywords: fda, accepts, b-ms/imclone, erbitux, sbla, biotechnology, firm

FDA accepts B-MS/ImClone's Erbitux sBLA

Article | 10 November 2008

Print This

US biotechnology firm ImClone Systems and drug major and Bristol-Myers Squibb say that the Food and Drug Administration has accepted ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in